Beryl Drugs standalone net profit declines 74.07% in the September 2018 quarter
Sales rise 9.01% to Rs 3.51 crore
Net profit of Beryl Drugs declined 74.07% to Rs 0.14 crore in the quarter ended September 2018 as against Rs 0.54 crore during the previous quarter ended September 2017. Sales rose 9.01% to Rs 3.51 crore in the quarter ended September 2018 as against Rs 3.22 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales3.513.22 9 OPM %9.977.45 -PBDT0.290.21 38 PBT0.250.11 127 NP0.140.54 -74Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2018 | 10:48 AM IST